Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia
OBJECTIVE: A publicly funded, universal infant pentavalent rotavirus vaccine (RV5) program was implemented in Queensland, Australia, in mid-2007. We sought to assess vaccine effectiveness (VE) of 3 doses of RV5 at preventing rotavirus and nonrotavirus acute gastroenteritis (AGE) hospitalizations in the first birth cohort and impact on hospitalizations in all age groups. METHODS: Hospitalization rates for rotavirus and nonrotavirus AGE in all age groups before and after RV5 introduction were...[Show more]
|Collections||ANU Research Publications|
|Source:||Pediatrics (English edition)|
|01_Field_Pentavalent_rotavirus_vaccine_2010.pdf||521.1 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.